Clinical Trial Update: Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports ongoing Phase 1/2 studies evaluating the Ga-68-labeled NI-FAPI-04 PET/CT imaging agent for fibroblast activation protein–rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiovascular Disease
• Fibroblast Activation Protein-related Diseases
• Giant Cell Arteritis
• Hypertrophic Cardiomyopathy
• Large Vessel Vasculitis
• Pulmonary Fibrosis
• Takayasu Arteritis

Drugs mentioned

• 68Ga-NI-FAPI-04 (Gallium-68 labeled NI-FAPI-04)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Tumor, Cardiovascular Diseases | Phase 1, Phase 2 | Status: RECRUITING